Sector portfolio · VC firm · United States
Insight Partners' Biotech portfolio
Insight Partners has backed 18 Biotech startups in rounds we track, $1.2B between them, shown by the stage each has reached. The best-funded is Averna Therapeutics.
Insight Partners's whole portfolioInsight Partners's profile
Funding by segment
- Series A$635M8
- Series B$253M4
- Stage not reported$153M3
- Series C and later$170M3
Where they are based
- United States15$967M
- Netherlands1$138M
United States
NetherlandsFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M7
- $50M to $250M11
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 18 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States15
- Netherlands1
Startups by country, 2 countries in all.
Segment by segment
Series A
8 startups · $635M raised
Averna TherapeuticsAverna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.United States$170M
VectorYVectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020.Netherlands$138M
TwoStep TherapeuticsTwoStep Therapeutics is a biotechnology company focused on developing targeted therapies for solid tumors.United States$84M
Exsilio TherapeuticsExsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.-$82M
Switch TherapeuticsSwitch Therapeutics is a preclinical-stage biotechnology company founded in 2020, focused on developing innovative RNA interferencUnited States$52M
PhaseVPhaseV is a Boston-based technology company founded in 2023 that specializes in optimizing clinical development for biopharma sponUnited States$50M
Capacity BioCapacity Bio is a biotechnology company founded in 2021 that specializes in developing therapeutics aimed at mitophagy, the procesUnited States$35M- CSCondor Software-$24M
Series B
4 startups · $253M raised
Kyverna TherapeuticsKyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.United States$160M
858 Therapeutics858 Therapeutics is a clinical-stage biotechnology company based in San Diego, California, founded in 2019.United States$50M
ProseProse is a made-to-order haircare and skincare company that specializes in creating customized products tailored to individual needs.United States$23M
CaremergeCaremerge is a provider of Senior Living Electronic Health Record (EHR) and Resident Engagement Solutions, aimed at enhancing the United States$20M
Stage not reported
3 startups · $153M raised
Insightful ScienceInsightful Science provides software designed to support scientists with research and development procedures.United States$95M
NanoMosaicNanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.United States$44M- EHEden HealthUnited States$14M
Series C and later
3 startups · $170M raised
LeanTaaSLeanTaaS is a software company that uses advanced data science to significantly improve the operational performance of hospitals aUnited States$84M
ProsciaProscia is a Philadelphia-based software company founded in 2014 that focuses on transforming pathology from traditional methods tUnited States$59M
Florence HealthcareFlorence Healthcare is a leader in clinical trial operations software, headquartered in Atlanta, Georgia.United States$27M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Insight Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Insight Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.